21 records matched your query
01715aam a2200385Ia 4500 001 81E75D38FE5F11E2B6A414D3DAD10320 003 SILO 005 20130806010419 006 m d f 007 cr an||||||||| 008 090615s2006 mdu s f000 0 eng d 035 $a (OCoLC)399838071 040 $a GPO $c GPO $d MvI $d SILO 074 $a 0499-T (online) 086 0 $a HE 20.4702:IM 7/2 245 00 $a Guidance for industry $h [electronic resource] : $b Q3B(R2) impurities in new drug products. 246 30 $a Q3B(R2) impurities in new drug products 246 30 $a Impurities in new drug products 260 $a Rockville, MD : $b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, $c [2006] 300 $a 8 p. : $b digital, PDF file. 538 $a Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL. 500 $a Title from PDF title page (viewed on June 15, 2009). 500 $a "ICH". 500 $a "July 2006". 500 $a "Revision 2". 650 0 $a Drug development $x Government policy $z United States. 650 0 $a Drug adulteration $x Government policy $z United States. 710 2 $a Center for Drug Evaluation and Research (U.S.) 710 2 $a Center for Biologics Evaluation and Research (U.S.) 711 2 $a International Conference on Harmonisation 856 40 $u http://purl.access.gpo.gov/GPO/LPS113762 941 $a 2 952 $l UPAX334 $d 20230104041655.0 952 $l USUX851 $d 20160824030046.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=81E75D38FE5F11E2B6A414D3DAD10320Initiate Another SILO Locator Search